Showing 5,845 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

PrEP

Two Thirds of Oral PrEP-Using MSM Would Switch to Long-Term Shots

Editor's pick
NATAP
26 October 2016
PrEP

More Surprises From ÉCLAIR: Cabotegravir's 'Long Tail'

Editor's pick
Medscape (requires free registration)
26 October 2016
Weight gain & lipodystrophy

The benefit of treatment has outweighed the clinical impact of lipodystrophy, conference hears

News
26 October 2016
Side effects

Dolutegravir and central nervous system side-effects: abacavir, older age increase the risk

News
25 October 2016
Changing treatment

Two-drug HIV therapy just as effective as three-drug therapy

News
25 October 2016
New & experimental HIV treatments

New nanomedicine approach aims to improve HIV drug therapies

Editor's pick
Science Daily
24 October 2016
News about aidsmap

Launch of About HIV / Pro VICH website

News
23 October 2016
Vaginal rings & topical PrEP

Rings, films or inserts? Researchers need to develop prevention products that make sense in women’s lives

News
21 October 2016
PrEP science

Second case report of PrEP failure due to drug-resistant virus

News
18 October 2016
The search for a cure

Crohn’s disease drug produces long-lasting viral undetectability and T-cell restoration off treatment in monkeys

News
14 October 2016
Side effects

Doctors in Netherlands observe higher than expected dolutegravir treatment discontinuation rate

News
13 October 2016
Adherence

Less than 100% adherence to HIV therapy, even with viral suppression, can lead to more inflammation and immune activation

News
12 October 2016
Economic & social inequality

Educational attainment associated with health outcomes after starting HIV therapy

News
11 October 2016
Child developmental issues

No evidence that contaminated nelfinavir led to increased risk of birth abnormalities or cancer

News
10 October 2016
Global health targets

Promising trends continue in UK diagnosis and treatment rates

News
7 October 2016
Hepatitis B

Hepatitis B testing should be done before hepatitis C treatment due to risk of HBV reactivation

News
7 October 2016
The search for a cure

'Infuriating': People With HIV, Doctors, Advocates Speak Out on Bad 'HIV Cure' Reporting

Editor's pick
The Body
5 October 2016
HIV treatment

Integrase inhibitors associated with improved viral suppression in HIV

Editor's pick
Healio
29 September 2016
Young people

UNC Receives $18 Million to Combine Tech & Health

Editor's pick
University of North Carolina Institute for Global Health & Infectious Diseases
28 September 2016
Hepatitis C treatment

EASL issues new hepatitis C treatment recommendations for all genotypes

News
26 September 2016
Viral load

Spanish study gives reassurance: small HIV blips do not predict treatment failure

News
21 September 2016
Adherence

Four day a week ART: sub-optimal drug levels but few virological failures

Editor's pick
HIV i-Base
20 September 2016
Changing treatment

Ask A Pharmacist: With a new tenofovir, should you switch to Descovy, Genvoya or Odefsey?

Editor's pick
BETA blog
20 September 2016
Pharmaceutical industry

Janssen Submits Marketing Authorisation Application for Darunavir-Based Single Tablet Regimen for Treatment of HIV-1 to European Medicines Agency

Editor's pick
Janssen-Cilag press release
13 September 2016